Perlen Packaging is part of Chemie + Papier Holding (CPH), an international industrial group specialising in chemicals, paper and packaging films. Perlen Packaging is focused on film manufacturing and film coating for the pharmaceutical industry. The company is headquartered in Switzerland, but also has also opened or acquired sites in Germany, the US and, most recently, in China.
“We specialise completely in the processes and production of PVC films and barrier films and we have all the necessary ISO certification and FDA approval. We provide the best quality available to the pharmaceutical industry,” says Wolfgang Grimm, CEO of Perlen Packaging.
Perlen Packaging has an extensive portfolio of highly effective pharma films, including a range of blister films and an innovative new transparent antimicrobial film coating.
The company works closely with suppliers to ensure it uses only the highest quality raw materials. Perlen audits its suppliers, and uses dedicated processes and trucks for the handling of the materials, to ensure the level of quality is retained. And new materials are sourced from suppliers, in order to innovate and bring new products to market.
Perlen Packaging is known for bringing out new products and making new developments,” says Wolfgang. “In the last couple of years we have successfully developed many new products, including the highest barrier films so our products are of a comparable standard to other products on the market – for example cold form blister packs.”
Perlen also ensures that its equipment is up-to-date, allowing the company to be cost effective and competitive. For example, as the technology becomes available, more processes are automated and monitored for greater output and efficiency.
The business will stay focused on pharma but Wolfgang sees the potential for Perlen to differentiate into different areas of pharmaceutical packaging. While today the company mostly creates packaging for solid dose medications, i.e. tablets, capsules etc., there is room to expand into providing solutions for medications in powder or liquid form.
“Chronic respiratory diseases, requiring asthma inhalers for example, are fast growing. I think we are going to introduce something to the market which goes in the direction of inhalers. That is one opportunity we see to expand our product range and our business, but stay focused on the pharmaceutical industry,” explains Wolfgang. “And we also have solutions available for eye care and other liquid products.”
Moving into these new areas will require working in cooperation with other companies in the packaging field. For example, in an inhaler, there are the packaging materials but also the designated machinery or mechanism for delivering the medication. It’s an opportunity to assist pharmaceutical companies in developing new products, supplying complete systems to the market that get the active ingredient where it’s needed.